Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 14:51 | 23 Apr | 599.35 |
11.50 (1.96%) |
OPEN
572.15 |
HIGH
599.75 |
LOW
572.15 |
| NSE 14:44 | 23 Apr | 599.95 |
10.90 (1.85%) |
OPEN
576.00 |
HIGH
600.85 |
LOW
576.00 |
| OPEN | 572.15 |
| PREVIOUS CLOSE | 587.85 |
| VOLUME | 138786 |
| 52-Week high | 663.00 |
| 52-Week low | 479.00 |
| P/E | 38.01 |
| Mkt Cap.(Rs cr) | 48,254 |
| Buy Price | 598.75 |
| Buy Qty | 167.00 |
| Sell Price | 599.30 |
| Sell Qty | 176.00 |
Cipla Ltd. (CIPLA) - Peer Group
| COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
| Sun Pharma.Inds. | 513.60 | 1.62 | 123228.04 | 6653.23 | 399.22 | 1.55 | 331.35 |
| Cipla | 599.35 | 1.96 | 48253.67 | 3913.82 | 404.32 | 15.77 | 38.01 |
| Piramal Enterp. | 2633.00 | 2.41 | 47459.82 | 2858.36 | 439.67 | 15.80 | 166.65 |
| Cadila Health. | 400.00 | 3.95 | 40948.00 | 3259.60 | 542.90 | 12.88 | 31.06 |
| Biocon | 633.00 | -0.71 | 37980.00 | 1057.90 | 113.60 | 6.17 | 102.59 |
| Aurobindo Pharma | 642.85 | 3.94 | 37664.58 | 4336.11 | 594.86 | 33.45 | 19.22 |
| Lupin | 814.35 | 2.00 | 36816.76 | 3975.62 | 222.23 | 35.42 | 22.99 |
| Dr Reddy's Labs | 2132.35 | 0.56 | 35379.95 | 3834.10 | 294.20 | 36.97 | 57.68 |
| Divi's Lab. | 1182.50 | -0.95 | 31389.46 | 820.70 | 231.47 | 32.67 | 36.20 |
| Torrent Pharma. | 1404.20 | 0.51 | 23761.87 | 1477.00 | 58.00 | 22.22 | 63.20 |
| Alkem Lab | 1809.00 | 1.86 | 21626.59 | 1740.47 | 180.87 | 65.13 | 27.78 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
